Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Physiology & Behavior
|
June 12, 2022
Cardiovascular reactivity during sadness induction predicts inhibitory control performance
Alexandra Hoffmann, Philipp Ellmerer, Thomas Maran, et al.
Frontiers in Neurology
|
June 27, 2018
Eye-Tracking Provides a Sensitive Measure of Exploration Deficits After Acute Right MCA Stroke
Margarete Delazer, Martin Sojer, Philipp Ellmerer, et al.
Brain Sciences
|
April 3, 2021
Birds of a Feather Flock Together: Disadvantageous Decision Making in Augmented Restless Legs Syndrome Patients with and without Impulse Control Disorders
Beatrice Heim, Philipp Ellmerer, Ambra Stefani, et al.
European Journal of Neurology
|
December 19, 2021
Factors associated with augmentation in patients with restless legs syndrome
Beatrice Heim, Philipp Ellmerer, Ambra Stefani, et al.
Movement Disorders Clinical Practice
|
July 18, 2022
Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis
Marina Peball, Beatrice Heim, Philipp Ellmerer, et al.
Sleep Medicine
|
September 30, 2020
The Frontal Assessment Battery in RLS patients with and without augmentation
Philipp Ellmerer, Ambra Stefani, Beatrice Heim, et al.
Brain and Behavior
|
September 26, 2020
Time will tell: Decision making in premanifest and manifest Huntington's disease
Beatrice Heim, Marina Peball, Carsten Saft, et al.
Neuro-Degenerative Diseases
|
October 27, 2021
Tit for Tat: Costly Punishment in Manifest Huntington's Disease
Beatrice Heim, Marina Peball, Carsten Saft, et al.
Journal of Parkinson'S Disease
|
April 3, 2023
Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease
Marina Peball, Dora Valent, Anna Grossauer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 27, 2019
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
Marina Peball, Mario Werkmann, Philipp Ellmerer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Physiology & Behavior
|
June 12, 2022
Cardiovascular reactivity during sadness induction predicts inhibitory control performance
Alexandra Hoffmann, Philipp Ellmerer, Thomas Maran, et al.
Frontiers in Neurology
|
June 27, 2018
Eye-Tracking Provides a Sensitive Measure of Exploration Deficits After Acute Right MCA Stroke
Margarete Delazer, Martin Sojer, Philipp Ellmerer, et al.
Brain Sciences
|
April 3, 2021
Birds of a Feather Flock Together: Disadvantageous Decision Making in Augmented Restless Legs Syndrome Patients with and without Impulse Control Disorders
Beatrice Heim, Philipp Ellmerer, Ambra Stefani, et al.
European Journal of Neurology
|
December 19, 2021
Factors associated with augmentation in patients with restless legs syndrome
Beatrice Heim, Philipp Ellmerer, Ambra Stefani, et al.
Movement Disorders Clinical Practice
|
July 18, 2022
Hospital Admissions of Huntington's Disease Patients in a Huntington's Disease Centre Between 2011 and 2016: A Retrospective Analysis
Marina Peball, Beatrice Heim, Philipp Ellmerer, et al.
Sleep Medicine
|
September 30, 2020
The Frontal Assessment Battery in RLS patients with and without augmentation
Philipp Ellmerer, Ambra Stefani, Beatrice Heim, et al.
Brain and Behavior
|
September 26, 2020
Time will tell: Decision making in premanifest and manifest Huntington's disease
Beatrice Heim, Marina Peball, Carsten Saft, et al.
Neuro-Degenerative Diseases
|
October 27, 2021
Tit for Tat: Costly Punishment in Manifest Huntington's Disease
Beatrice Heim, Marina Peball, Carsten Saft, et al.
Journal of Parkinson'S Disease
|
April 3, 2023
Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease
Marina Peball, Dora Valent, Anna Grossauer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 27, 2019
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
Marina Peball, Mario Werkmann, Philipp Ellmerer, et al.
Page
of 3